Results 211 to 220 of about 48,636 (310)

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, Volume 78, Issue 3, Page 566-581, March 2026.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Prevalence of CD20 positive B-cells in peripheral blood of patients with lymphocytic lymphoma and correlation with the course of disease [PDF]

, 1994
Emmerich, B., Langenmayer, Irmgard, Pachmann, K., Straka, C.   +3 more
core   +1 more source

B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic Diseases. [PDF]

CPT Pharmacometrics Syst Pharmacol
Nakada T, Mager DE.
europepmc   +1 more source

Elucidating the Causal Relationships Between B Cells, Dendritic Cells, and Multiple Sclerosis Pathogenesis

Brain and Behavior, Volume 16, Issue 3, March 2026.
This study presents an integrative pipeline linking immune cell traits to multiple sclerosis (MS) susceptibility. Genome‐wide association and Mendelian randomization analyses revealed causal roles of immune cells in MS risk. Colocalization and pleiotropy mapping identified candidate genes, further refined through functional annotation, network analysis,
Xuefei Wang, Yangwei Wang, Xiaojing Liu
wiley   +1 more source

Rituximab in Connective Tissue Disease-Associated Interstitial Lung Disease: From Immunopathogenesis to Therapeutic Implications. [PDF]

Int J Mol Sci
Chatzis D, Banos A, Fanouriakis A, Karampitsakos T, Tzilas V.   +4 more
europepmc   +1 more source

The Emerging Role of Tertiary Lymphoid Structures as Predictive and Prognostic Biomarkers of Immunotherapy in Cancer

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Immune checkpoint inhibitors (ICIs) have improved outcomes across several cancers, yet many patients do not respond, highlighting the need for robust predictive biomarkers. Tertiary lymphoid structures (TLS), ectopic lymphoid aggregates that support local antigen presentation and adaptive immune activation, have emerged as potential
Lidia B. Medhin, Rodas Amanuel, Lydia Warburton, Leslie Calapre, Benhur Amanuel, Elin S. Gray   +5 more
wiley   +1 more source

Novel immunotherapeutic strategies for diffuse large B-cell lymphoma: a comprehensive review. [PDF]

Front Immunol
Li Y, Zhang Y, Zhu C, Han Y, Gao X, Yue J, Wang Y.   +6 more
europepmc   +1 more source

Tumor‐Infiltrating Immune Cells Are More Abundant in Lung Metastases From Colorectal Cancer Than in Paired Primary Tumors and Their Prognostic Value Depends on Adjuvant Chemotherapy

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Introduction The immune microenvironment plays a crucial role in the progression of colorectal cancer (CRC), but its variation across primary tumors and metastatic sites remains incompletely understood. In this study, we compared the composition and prognostic significance of the immune microenvironment in lung metastases, paired primary ...
Danyil Kuznyecov, Christina Siesing, Halla Vidarsdottir, Jakob Eberhard, Hans Brunnström, Karin Leandersson, Karin Jirström   +6 more
wiley   +1 more source

Histological changes of conjunctiva-associated lymphoid tissue caused by pneumonia in Holstein young cows. [PDF]

Vet Anim Sci
Kosenda K, Ishiguro Y, Sano Y, Matsuda K, Sugiura T, Murakami T, Sato A, Ohtsuka H, Fukuda S, Kon Y, Namba T, Ichii O.   +11 more
europepmc   +1 more source

Primary Diffuse Large B‐Cell Lymphoma Mimicking a Dental Abscess: A Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, yet its presentation in the maxillofacial region can pose diagnostic challenges, particularly in patients with confounding medical histories. We report the case of a 40‐year‐old Iranian male with a history of ulcerative colitis on mesalazine therapy, who ...
Haniyeh Najafi Aghdam, Ladan Paya, Mina Zohrabi   +2 more
wiley   +1 more source